Decibel Therapeutics, Inc. Comprehensive Income
Decibel Therapeutics, Inc. reported Comprehensive Income of -$18.12 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-08-11
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$18.12M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$13.14M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$15.66M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$15.92M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$63.10M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$51.95M.
- Decibel Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$39.35M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$18.12M 10-Q · filed 2023-08-11 | -$31.26M 10-Q · filed 2023-08-11 | -$46.92M derived: sum of 3 quarters · filed 2023-08-11 | -$62.84M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | -$13.14M 10-Q · filed 2023-05-15 | -$28.80M derived: sum of 2 quarters · filed 2023-05-15 | -$44.72M derived: sum of 3 quarters · filed 2023-05-15 | -$61.83M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | -$15.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$31.58M derived: sum of 2 quarters · filed 2023-03-14 | -$48.69M derived: sum of 3 quarters · filed 2023-08-11 | -$63.10M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$15.92M 10-Q · filed 2022-11-09 | -$33.03M derived: sum of 2 quarters · filed 2023-08-11 | -$47.44M 10-Q · filed 2022-11-09 | -$60.48M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | -$17.11M 10-Q · filed 2023-08-11 | -$31.52M 10-Q · filed 2023-08-11 | -$44.56M derived: sum of 3 quarters · filed 2023-08-11 | -$60.96M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$14.41M 10-Q · filed 2023-05-15 | -$27.45M derived: sum of 2 quarters · filed 2023-05-15 | -$43.85M derived: sum of 3 quarters · filed 2023-05-15 | -$55.48M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$29.44M derived: sum of 2 quarters · filed 2023-03-14 | -$41.06M derived: sum of 3 quarters · filed 2023-03-14 | -$51.95M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$16.40M 10-Q · filed 2022-11-09 | -$28.02M derived: sum of 2 quarters · filed 2022-11-09 | -$38.91M 10-Q · filed 2022-11-09 | -$51.80M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$11.63M 10-Q · filed 2022-08-10 | -$22.52M 10-Q · filed 2022-08-10 | -$35.40M derived: sum of 3 quarters · filed 2022-08-10 | -$42.51M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$10.89M 10-Q · filed 2022-05-12 | -$23.77M derived: sum of 2 quarters · filed 2022-05-12 | -$30.89M derived: sum of 3 quarters · filed 2022-05-12 | -$38.69M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$20.00M derived: sum of 2 quarters · filed 2022-03-18 | -$27.80M derived: sum of 3 quarters · filed 2022-03-18 | -$39.35M 10-K · filed 2022-03-18 |
| 2020-09-30 | -$7.11M 10-Q · filed 2021-11-10 | -$14.92M derived: sum of 2 quarters · filed 2021-11-10 | -$26.46M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$7.81M 10-Q · filed 2021-08-10 | -$19.35M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$11.54M 10-Q · filed 2021-05-13 |